Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Life Sci ; 209: 1-8, 2018 Sep 15.
Article in English | MEDLINE | ID: mdl-30048695

ABSTRACT

Alcohol, a psychoactive drug is one of the lifestyle factors responsible for male infertility. Present study was carried out to investigate the ameliorative effect of p­coumaric acid (PCA), a plant derived bioactive phenolic compound on alcohol induced chronic reproductive toxicity in male rats. Thirty male Wistar rats were divided into five groups, each with six animals. Group I as control received vehicle (distilled water) alone. And the following Group II, III, IV, V were treated orally with sequentially (per week) increased dose of ethanol 25% v/v (5, 8, 10 and 12 g/kg b wt per week in each group) for 28 days. On the 3rd and 4th week, the groups III, IV, V were administered with p­coumaric acid orally at three different concentrations (Low 50 mg/kg b wt; Medium 100 mg/kg b wt; High 200 mg/kg b wt). The rats treated with ethanol showed abnormal sperm characteristics, reduced anti-oxidant level, reduced testosterone level and abnormal testicular histoarchitecture while the rats treated with PCA in addition to ethanol were found to have protective effects on sperm parameters and apoptosis. The increased caspase-3, caspase-7, p21 immunoreactivity and reduced Cdk4 immunoreactivity in ethanol treated rats confirmed that ethanol increases the apoptosis in testis and a reduced expression in the rats treated with PCA in addition to ethanol indicates a protective role of PCA. Overall, our results showed that PCA mitigates alcohol induced male reproductive toxicity and improves reproductive health in male Wistar rats.


Subject(s)
Coumaric Acids/pharmacology , Ethanol/toxicity , Infertility, Male/prevention & control , Protective Agents/pharmacology , Animals , Anti-Infective Agents, Local/toxicity , Infertility, Male/chemically induced , Male , Rats , Rats, Wistar , Spermatozoa/chemistry , Spermatozoa/drug effects , Testis/drug effects
2.
Biomed Pharmacother ; 94: 1028-1037, 2017 Oct.
Article in English | MEDLINE | ID: mdl-28813782

ABSTRACT

Ammonia is a well-known neurotoxin that causes liver disease and urea cycle disorder. Excessive ammonia content in the blood leads to hyperammonemic condition and affects both excitatory and inhibitory neurotransmission including brain edema and coma. Naringin, a plant bioflavonoid present in various citrus fruits and mainly extracted from the grape fruit. This study was designed to assess the protective effect of naringin on ammonium chloride (NH4Cl) induced hyperammonemic rats. Experimental hyperammonemia was induced by intraperitoneal injections (i.p) of NH4Cl (100mg/kg body weight (b.w.)) thrice a week for 8 consecutive weeks. Hyperammonemic rats were treated with naringin (80mg/kg b.w.) via oral gavage. Naringin administration significantly augmented the level of blood ammonia and plasma urea. Naringin also upregulate the expression of urea cycle enzymes such as carbamoyl phosphate synthase I (CPS I) and ornithine transcarbamylase (OTC), arininosuccinate synthase (ASS), argininosuccinate lyase (ASL) and arginase I (ARG) and metabotropic glutamate receptors (mGluRs) such as mGluRs I and mGluRs V and down regulate the expression of inflammatory markers like tumor necrosis factor (TNF-α), nuclear factor kappa B (NF-kB), Interleukin-6 (IL-6), inducible nitric oxide synthase (iNOS). In addition, to this, the protective effect of naringin was also revealed through the immunohistochemical changes in tissues. Thus our present study result suggest that naringin modulates the expression of proteins involved in urea cycle pathway and suppresses the expression of inflammatory markers and acts as a potential agent to treat condition in rats.


Subject(s)
Ammonium Chloride/pharmacology , Flavanones/pharmacology , Hyperammonemia/drug therapy , Urea/metabolism , Animals , Biomarkers/metabolism , Down-Regulation/drug effects , Flavonoids/pharmacology , Hyperammonemia/chemically induced , Hyperammonemia/metabolism , Inflammation/drug therapy , Inflammation/metabolism , Interleukin-6/metabolism , Liver/drug effects , Liver/metabolism , Male , Nitric Oxide Synthase Type II/metabolism , Rats , Rats, Wistar , Tumor Necrosis Factor-alpha/metabolism , Up-Regulation/drug effects
3.
Biomed Pharmacother ; 84: 1717-1726, 2016 Dec.
Article in English | MEDLINE | ID: mdl-27836465

ABSTRACT

Naringin, plant bioflavonoid extracted mainly from grapefruit and other related citrus species. This study was designed to assess the neuroprotective effect of naringin on ammonium chloride (NH4Cl) induced hyperammonemic rats. Experimental hyperammonemia was induced by intraperitonial injection (i.p) of NH4Cl (100mg/kg body weight (b.w.)) thrice a week for 8 consecutive weeks. Hyperammonemic rats were treated with naringin (80mg/kg b.w.) via oral gavage. Naringin administration drastically restored the levels of blood ammonia, plasma urea, nitric oxide (NO), glutamate, glutamine, lipid peroxidation, lipid profile, activities of liver marker enzymes, antioxidant status and sodium/potassium-ATPase (Na+/K+-ATPase). In addition, naringin supplementation reverted back the pathological changes of liver, brain and kidney tissues, the expressions of Glutamine synthetase (GS), Na+/K+-ATPase, neuronal nitric oxide (nNOS) and soluble guanylate cyclase (sGC) in hyperammonemic rats. Hence, this study suggested that nargingin exhibited their protective effect against NH4Cl induced toxicity via enhancing the activities of antioxidant enzymes and inhibiting the lipid peroxidation process. Take together, this study provides data that naingin effectively reduced neurotoxicity by attenuating hyperammonemia, suggesting that naringin act as a potential therapeutic agent to treat hyperammonemic rats.


Subject(s)
Ammonium Chloride , Cyclic GMP/metabolism , Flavanones/pharmacology , Glutamic Acid/blood , Hyperammonemia/drug therapy , Neuroprotective Agents/pharmacology , Neurotoxicity Syndromes/prevention & control , Nitric Oxide/blood , Ammonia/blood , Animals , Antioxidants/metabolism , Biomarkers/blood , Brain/drug effects , Brain/enzymology , Disease Models, Animal , Glutamate-Ammonia Ligase/genetics , Glutamate-Ammonia Ligase/metabolism , Hyperammonemia/blood , Hyperammonemia/chemically induced , Hyperammonemia/genetics , Kidney/drug effects , Kidney/enzymology , Lipid Peroxidation/drug effects , Lipids/blood , Liver/drug effects , Liver/enzymology , Male , Neurotoxicity Syndromes/blood , Neurotoxicity Syndromes/etiology , Neurotoxicity Syndromes/genetics , Nitric Oxide Synthase Type I/genetics , Nitric Oxide Synthase Type I/metabolism , Rats, Wistar , Signal Transduction/drug effects , Sodium-Potassium-Exchanging ATPase/genetics , Sodium-Potassium-Exchanging ATPase/metabolism , Soluble Guanylyl Cyclase/genetics , Soluble Guanylyl Cyclase/metabolism , Time Factors
4.
Biomed Pharmacother ; 84: 230-236, 2016 Dec.
Article in English | MEDLINE | ID: mdl-27662473

ABSTRACT

P-coumaric acid (p-CA, 3-[4-hydroxyphenyl]-2-propenoic acid), the major component widely found in nutritious plant foods, has various antioxidant, antiinflammatory and anticancer property. To evaluate the antidiabetic and antihyperlipidemic mechanisms, via the effects on carbohydrate, lipids and lipoproteins responses in adult male albino Wistar rats were examined by treated with p-CA. Rats were injected with streptozotocin (STZ, 40mg/kg b.w.) by intraperitonially (i.p.) 30days for the induction of experimental diabetes mellitus. Diabetic rats were treated with p-CA orally at a dose of 100mg/kg b.w. The potential defending character of p-CA against diabetic rats was evaluated by performing the various biochemical parameters and glucose transporter such as GLUT2 mRNA expression of pancreas. Administration of p-CA significantly lowers the blood glucose level, gluconeogenic enzymes such as glucose-6-phosphatase and fructose-1,6-bisphosphatase whereas increases the activities of hexokinase, glucose-6 phosphatase dehydrogenase and GSH via by increasing level of insulin. p-CA reduces the total cholesterol and triglycerides in both plasma and tissues i.e. liver and kidney. p-CA also decreases the LDL-C, VLDL-C and it considerably increase the level of HDL-C. A significant decreased expression of GLUT 2 mRNA in the pancreas was recorded in the supplementation of p-CA treated groups. Taken together, these results suggest that p-CA modulates glucose and lipid metabolism via GLUT 2 activation in the pancreatic and has potentially beneficial effects in improving or treating metabolic disorders.


Subject(s)
Blood Glucose/drug effects , Coumaric Acids/pharmacology , Diabetes Mellitus, Experimental/drug therapy , Glucose Transporter Type 2/drug effects , Hypoglycemic Agents/pharmacology , Hypolipidemic Agents/pharmacology , Lipids/blood , Pancreas/drug effects , Animals , Biomarkers/blood , Blood Glucose/metabolism , Diabetes Mellitus, Experimental/blood , Diabetes Mellitus, Experimental/chemically induced , Down-Regulation , Glucose Transporter Type 2/genetics , Glucose Transporter Type 2/metabolism , Glutathione/metabolism , Insulin/blood , Kidney/drug effects , Kidney/metabolism , Liver/drug effects , Liver/metabolism , Male , Pancreas/metabolism , Propionates , RNA, Messenger/genetics , RNA, Messenger/metabolism , Rats, Wistar , Streptozocin
5.
Biomed Pharmacother ; 82: 345-54, 2016 Aug.
Article in English | MEDLINE | ID: mdl-27470372

ABSTRACT

Chrysin (5,7-dihydroxyflavone) is a major component of some traditional medicinal herbs present in honey, propolis and many plant extracts. The study was aimed to illuminate the effect of chrysin in the pathogenesis of ammonium chloride (NH4Cl) induced hyperammonemic rat model in a dose dependent manner. Rats were injected with NH4Cl (100mg/kg b.w.) by intraperitonially (i.p) thrice a week for 8 consecutive weeks for the induction of experimental hyperammonemia. Hyperammonemic rats were treated with chrysin by orally at a dose of 25, 50 & 100mg/kg b.w. respectively. Protective effect of chrysin against hyperammonemia was evaluated by performing biochemical estimations and morphopathological investigations of hematoxylin and eosin stained sections of liver, brain and kidney tissues. Supplementation of chrysin reinstated the levels of blood ammonia, plasma urea, uric acid, total bilirubin, creatinine, brain glutamate, glutamine, nitric oxide (NO) and the activities of Na(+)/K(+)-ATPase, and liver marker enzymes. On the other hand increased level of plasma urea was observed in chrysin treated rats as compared with hyperammonemic rats. Chrysin administration caused distortion of hepatic, brain and kidney architecture as shown by histological examination. Chrysin at a dose (100mg/kg b.w.) showed an utmost decline in the level of all biochemical estimations. Both biochemical and morphological studies clearly revealed that chrysin protects against cell injury induced by ammonia intoxication in a dose-response manner with respect to endogenous antioxidants and hypoammonemic effects.


Subject(s)
Flavonoids/therapeutic use , Hyperammonemia/drug therapy , Hyperammonemia/pathology , Ammonia/blood , Animals , Bilirubin/blood , Biomarkers/metabolism , Body Weight/drug effects , Brain/drug effects , Brain/metabolism , Creatinine/blood , Dose-Response Relationship, Drug , Flavonoids/chemistry , Flavonoids/pharmacology , Glutamic Acid/metabolism , Glutamine/metabolism , Hyperammonemia/blood , Kidney/drug effects , Kidney/pathology , Liver/drug effects , Liver/enzymology , Liver/pathology , Male , Models, Biological , Nitric Oxide/metabolism , Rats, Wistar , Sodium-Potassium-Exchanging ATPase/metabolism , Urea/blood , Uric Acid/blood
SELECTION OF CITATIONS
SEARCH DETAIL
...